A new effector pathway links ATM kinase with the DNA damage response

Nature Cell Biology

Volumn 6, Issue 10, 2004, Pages 968-976

  Demonacos, Constantinos ^a,b   Krstic Demonacos, Marija ^a,b   Smith, Linda ^a   Xu, Danmei ^a   O'Connor, Darran P ^a   Jansson, Martin ^a   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DNA; PROTEIN KINASE; PROTEIN P53; SERINE; TRANSCRIPTION FACTOR;

ACETYLATION; ARTICLE; ATAXIA TELANGIECTASIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL EXTRACTS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DNA DAMAGE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MUTATION; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SERINE; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 5444271774     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1170     Document Type: Article

References (36)

1. Zhou, B. B. & Elledge, S. J. The DNA damage response: putting checkpoints in perspective. Nature 408, 433-439 (2000).
2. Abraham, R. T. Cell cycle checkpoint signalling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196 (2001).
3. Khanna, K. K., Lavin, M. F., Jackson, S. P. & Mulhern, T. D. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 8, 1052-1065 (2001).
4. Shiloh, Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11, 71-77 (2001).
5. Walworth, N. C. Cell-cycle checkpoint kinases: checking in on the cell cycle. Curr. Opin. Cell Biol. 2, 697-704 (2000).
6. Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
7. Khosravi, R. et al. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl Acad. Sci. USA 96, 14973-14977 (1999).
8. Maya, R. et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067-1077 (2001).
9. Cortez, D., Wang, Y., Qin, J. & Elledge, S. J. Requirement of ATM-dependgnt phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science 286, 1162-1166 (1999).
10. Hirao, A. et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827 (2000).
11. Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y. & Prives, C. The human homologues of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289-300 (2000).
12. Falck, J., Mailand, N., Syljuasen, R. G., Bartek, J. & Lukas, J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-847 (2001).
13. Stevens, C., Smith, L. & La Thangue, N. B. Checkpoint kinase activates E2F-1 in response to DNA damage. Nature Cell Biol. 5, 401-409 (2003).
14. Peng, C. Y. et al. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505 (1997).
15. Lakin, N. D. & Jackson, S. P. Regulation of p53 in response to DNA damage. Oncogene 18, 7644-7655 (1999).
16. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
17. 1 by stabilizing p53. Genes Dev. 14, 278-288 (2000).
18. Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983 (1998).
19. Meyn, M. S. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin. Genet. 55, 289-304 (1999).
20. Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528-2531 (1999).
21. Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841 (1998).
22. Liu, L. et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19, 1202-1209 (1999).
23. Avantaggiati, M. L. et al. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1184 (1997).
24. Shikama, N. et al. A novel cofactor for p300 that regulates the p53 response. Mol. Cell 4, 365-376 (1999).
25. Demonacos, C., Krstic-Demonacos, M. & La Thangue, N. B. A TPR motif cofactor contributes to p300 activity in the p53 response. Mol. Cell 8, 71-84 (2001).
26. Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intramolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003).
27. Barlow, C. et al. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 96, 9915-9919 (1999).
28. Beamish, H. & Lavin, M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65, 175-184 (1994).
29. Sarkaria, J. N., et al. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res. 58, 4375-4382 (1998).
30. Stein, R. C. & Waterfield, M. D. PI3-kinase inhibition: a target for drug development? Mol. Med. Today 6, 347-357 (2000).
31. Di Tullio, R. A. et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nature Cell Biol. 4, 998-1002 (2002).
32. Chan, H- M. & La Thangue, N. B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114, 2363-2373 (2001).
33. Gu, W. & Roeder, R. G. Activation of p53 sequence specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (1997).
34. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288-7293 (1998).
35. Crighton, D. et al. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J. 22, 2810-2820 (2003).
36. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).